Diagnostic Testing During a Pandemic
A digital health company’s quest to improve the delivery and scaling of lab testing
Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Recent Videos
Related Content
